L57 acetate
Based on 1 Customer Validation
L57 acetate is a Low-density lipoprotein receptor-related protein 1 (LRP1)-binding peptide. L57 acetate exhibits high affinity to LRP1 with Ki of 45 nM. L57 acetate exhibits blood-brain barrier (BBB) permeability and plasma stability. L57 acetate can be utilized as the carrier for CNS drug delivery.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté: 99.01%
- Formule: C120H175N31O27.xC2H4O2
- Masse moléculaire:2483.87 (free base)
-
Stockage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Activité biologique
L57 (EC50-determining concentrations; 1 h) acetate selectively binds to recombinant human LRP1(CL4)-Fc with an EC50 of 45 nM in a plate ELISA assay[1].
Fluorescein-labeled L57 (3-30 μM; 4 h, 1 min) exhibits rapid, concentration-dependent, LRP1-mediated uptake in primary rat BMVECs and astrocytes, with significantly higher uptake efficiency than the reference peptide at matching concentrations, and shows limited uptake in LRP1-deficient PEA 10 cells[2].
Fluorescein-labeled L57 (3-30 μM; 4 h) shows excellent biocompatibility with no cytotoxicity observed in primary rat BMVECs or LRP1-deficient PEA 10 cells at concentrations up to 30 μM after 4 h of incubation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Primary rat brain microvascular endothelial cells (BMVECs), LRP1-deficient PEA 10 mouse embryonic fibroblasts
-
Concentration:3 μM, 10 μM, 30 μM
-
Incubation Time:4 h
-
Result:Resulted in high cell viability in both BMVECs and PEA 10 cells, with metabolic activity comparable to vehicle control conditions at all tested concentrations.
L57 (i.v.; single dose) acetate results in modest brain delivery in male C57BL/6J mice, with a % input value of 0.042[1].
L57 acetate demonstrates significant blood-brain barrier permeability and high LRP1 binding affinity in healthy mice, supporting its potential as a CNS drug delivery vector[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Appearance Solid
-
Masse moléculaire 2483.87 (free base)
-
Formule C120H175N31O27.xC2H4O2
-
Color White to off-white
-
Sequence
Thr-Trp-Pro-Lys-His-Phe-Asp-Lys-His-Thr-Phe-Tyr-Ser-Ile-Leu-Lys-Leu-Gly-Lys-His
-
Sequence Shortening
TWPKHFDKHTFYSILKLGKH
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Pureté et documentation
-
Fiche technique (275 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Instruction de manipulation (2659 KB)
Références
[1]. Sakamoto K, et al., A novel LRP1-binding peptide L57 that crosses the blood brain barrier. Biochem Biophys Rep. 2017 Aug 12;12:135-139. [Content Brief]
[2]. Rodrigues JP, et al. Efficient LRP1-Mediated Uptake and Low Cytotoxicity of Peptide L57 In Vitro Shows Its Promise as CNS Drug Delivery Vector. J Pharm Sci. 2021;110(2):824-832. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)